Figure 4: Analysis of surface expression of EDDR1 in normal and cancer cells: Normal liver and kidney cell suspensions obtained from healthy HLA-A2+ donors or cancer cell lines [ovarian cancer cell lines SKOV3-A2 and Ovcar3, breast cancer cell lines MDA-MB231 and MCF7 and a prostate cancer cell line LNCaP] were treated with either FITC-labeled isotype matched control antibody or FITC-labeled EDDR1 specific antibody and subjected to flow cytometry by Guava flow cytometer. Samples were analyzed using GuavaSoft software.